CASC2 and type 2 diabetes mellitus: The expression of lncRNA CASC2 is downregulated in T2DM patients with chronic renal failure but not T2DM patients with other complications, suggesting that lncRNA cancer susceptibility candidate 2 (CASC2) could also serve as a renal specific biomarker for DKD.